You are viewing an incomplete version of our website. Please click to reload the website as full version.

Reaction Buffer (20X)

Details for Product No. ABIN412380, Supplier: Log in to see
Application
Enzyme Activity Assay (EAA), Functional Studies (Func)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Comment

The 2X Reaction Buffer was optimized for caspase activity assay reactions. The buffer provides an economic reagent for researchers who perform large amount of caspase activity assays.

Restrictions For Research Use only
Format Liquid
Concentration 20 X
Storage 4 °C
Expiry Date 12 months
Product cited in: Ishdorj, Graham, Hu et al.: "Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC." in: The Journal of biological chemistry, Vol. 283, Issue 24, pp. 16818-29, 2008 (PubMed).

Zeitlin, Joo, Dong et al.: "Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2." in: Cancer research, Vol. 66, Issue 17, pp. 8698-706, 2006 (PubMed).

Wesche-Soldato, Chung, Lomas-Neira et al.: "In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice." in: Blood, Vol. 106, Issue 7, pp. 2295-301, 2005 (PubMed).

Ray, Akbiyik, Bernstein et al.: "CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 7, pp. 4060-9, 2005 (PubMed).

Mohammad, Wang, Aboukameel et al.: "Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma." in: Molecular cancer therapeutics, Vol. 4, Issue 1, pp. 13-21, 2005 (PubMed).

Nowak, Price, Schnellmann: "Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells." in: American journal of physiology. Renal physiology, Vol. 285, Issue 3, pp. F440-50, 2003 (PubMed).

Kawakami, Kawakami, Puri: "Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts." in: Molecular cancer therapeutics, Vol. 1, Issue 12, pp. 999-1007, 2002 (PubMed).

Nowak: "Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells." in: The Journal of biological chemistry, Vol. 277, Issue 45, pp. 43377-88, 2002 (PubMed).

Ghatak, Misra, Toole: "Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway." in: The Journal of biological chemistry, Vol. 277, Issue 41, pp. 38013-20, 2002 (PubMed).

Cummings, Schnellmann: "Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways." in: The Journal of pharmacology and experimental therapeutics, Vol. 302, Issue 1, pp. 8-17, 2002 (PubMed).

Vu, Bortner, Cidlowski: "Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death." in: The Journal of biological chemistry, Vol. 276, Issue 40, pp. 37602-11, 2001 (PubMed).

Ding, Lin, McGill et al.: "Essential role for caspase-8 in transcription-independent apoptosis triggered by p53." in: The Journal of biological chemistry, Vol. 275, Issue 49, pp. 38905-11, 2001 (PubMed).